GeekWire

MARCH 31, 2021

The news: Pharmaceutical giant Amgen agreed to acquire Rodeo Therapeutics, a Seattle biotech startup creating small-molecule therapies that help repair and regrow tissues. Amgen more recently partnered with Seattle biotech giant Adaptive Biotechnologies on COVID-related drug development. Rodeo Therapeutics CEO Thong Le.

Company 80

Company Biotechnology Pharmaceuticals Development 80

GeekWire

FEBRUARY 17, 2021

Notch Therapeutics is commercializing technologies developed in the labs of Juan-Carlos Zúñiga-Pflücker, left, chair of Notch’s scientific advisory board, and Chief Scientific Officer Peter Zandstra. The biotech company was founded in 2018 and is developing stem cell-derived immunotherapies for cancer. Notch Photo).

Biotechnology 116

Biotechnology Pharmaceuticals Research Development 116

GeekWire

JULY 19, 2021

Eliem has two lead drug candidates in development: ETX-810 for chronic pain conditions and ETX-155 for mood disorders and epilepsy. In June, Seattle-based Nautilus Biotechnology, led by Isilon Systems co-founder Sujal Patel, went public via a SPAC merger. It aims to raise up to $80 million with the IPO.

Biotechnology 107

Biotechnology Pharmaceuticals Groups Development 107

GeekWire

MAY 12, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue , to nearly $21 million. The goal is to develop therapies to treat the virus.

Biotechnology 93

Biotechnology Pharmaceuticals .Net Microsoft 93

CIO Business Intelligence

SEPTEMBER 18, 2023

According to the 2023 State of the CIO , IT leaders are looking to shore up competencies in key areas such as cybersecurity (39%), application development (30%), data science/analytics (30%), and AI/machine learning (26%). From an individual’s perspective, it keeps careers interesting and helps people grow with the organization.

Training 136

Training Pharmaceuticals Programming SAP 136

GeekWire

SEPTEMBER 14, 2020

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. billion if development milestones are met, and another $1.75

Biotechnology 72

Biotechnology Pharmaceuticals Journal Licensing 72

GeekWire

NOVEMBER 24, 2020

Frazier Healthcare Partners — which has invested in biotechnology companies since 1991 — filed with the Securities and Exchange Commission to raise $100 million for a special purpose acquisition corporation, also known as a SPAC. (Photo via Frazier). Sine 2010, its portfolio companies have received FDA approval for 30 drugs.

Biotechnology 63

Biotechnology Company Pharmaceuticals Healthcare 63

GeekWire

MARCH 18, 2021

“Her expertise of harmonizing hardware and software development in partnership with enterprise customers, and their engineering teams, will be a key component in our next phase of growth,” Johnson said of Trewin in a statement. Seattle-based Adaptive Biotechnologies appointed Leslie Trigg and Katey Owen to its board of directors.

Microsoft 100

Microsoft Biotechnology Pharmaceuticals Enterprise 100

GeekWire

JANUARY 14, 2021

AltPep is developing tools and treatments for diseases caused by amyloid proteins that are incorrectly folded and create harmful deposits. AltPrep is currently focused on Alzheimer’s and developing tools that can detect the illness even before someone is symptomatic. Athira went public last year.

Real Estate 145

Real Estate Biotechnology Pharmaceuticals Licensing 145

GeekWire

DECEMBER 8, 2022

— Maureen Ezekwugo is now CEO of Oggvo , which develops customer review management software for small- to medium-sized businesses. She is also a board member of Ada Developers Academy, a Seattle nonprofit. Maureen Ezekwugo. Oggvo Photo). The startup raised $10.7 A SPAC merger to take Intrinsic public recently fell through.

Real Estate 70

Real Estate Biotechnology Pharmaceuticals Financial 70

GeekWire

MARCH 12, 2022

Adaptive Biotechnologies had recently doubled its headcount as it turned to COVID-19 projects, but on Wednesday the Seattle company laid off 12% of its workforce, about 100 employees. University of Washington researchers have developed a device to detect the acidity of dental plaque using optical measurements. GeekWire Photo).

Biotechnology 82

Biotechnology Study Pharmaceuticals Research 82

CIO Business Intelligence

JUNE 22, 2023

While Silicon Valley still pays top dollar for IT pros, the war for talent has moved beyond the technology industry, with other verticals vying for talented IT workers who have the skills to enable digital transformation, process improvement, change management, and the development of apps and services.

Industry 122

Industry Project Management Quality Assurance Engineering 122

GeekWire

JANUARY 13, 2022

He was also VP of venture investments at Leaps by Bayer, the pharma giant’s investment arm, and he co-founded Exonics Therapeutics, which was acquired by Vertex Pharmaceuticals for $245 million. Affini-T is developing cancer treatments using a strategy called T cell receptor (TCR) cancer immunotherapy. Affini-T Photo).

Biotechnology 110

Biotechnology Pharmaceuticals Engineering Research 110

GeekWire

MARCH 18, 2022

The investment firm’s team includes senior associate Dasom (Christine) Yoo , former Fred Hutchinson Cancer Research Center business development manager. Kawas co-founded Athira (originally M3 Biotechnology) in 2011. Laursen , a pharmaceutical and biotechnology executive; Sylvia S. GeekWire Photo / Kevin Lisota). “I

Company 90

Company Biotechnology Research Journal 90

GeekWire

OCTOBER 7, 2020

Dr. Melanie Ivarsson, chief development officer at Moderna, one of the major pharmaceutical companies with a vaccine candidate in Phase 3 tests. Thursday, October 22: Education and Sana Biotechnology. Regence Health Tech Stage: Fireside chat with Steve Harr, CEO of Sana Biotechnology. Remote learning.

Education 132

Education Biotechnology Healthcare Banking 132

GeekWire

NOVEMBER 3, 2021

“Seattle is where I developed my career and it has been one of the most inspiring cities for growth and innovation both in leadership in diversity, equity, and inclusion and technology,” said Quiamno. . Daniel was one of the executives that developed and debuted Amazon’s recent wave of new consumer devices.

Microsoft 98

Microsoft Biotechnology Banking Engineering 98

GeekWire

JANUARY 5, 2022

The optimism that emerged with the successful development of COVID-19 vaccines and treatments continued to propel investment and advances through 2021. Hilary Hehman , vice president of business development at Fred Hutchinson Cancer Research Center. It’s been a remarkable few years for biotech, in the Pacific Northwest and beyond.

Industry 126

Industry Trends Biotechnology Research 126

GeekWire

JULY 13, 2021

Potential customers include pharmaceutical and biotechnology companies and other outside researchers interested in querying the data. Other companies may build on Truveta’s platform to find insights into patient care and develop clinical decision support, he said. “I

Healthcare 121

Healthcare System Data Insurance 121

GeekWire

DECEMBER 28, 2021

Pharmaceutical giant Bristol Myers Squibb has been quietly growing in the Seattle area. BMS has more than 150 open positions in the region, jostling with Sana Biotechnology, Umoja Biopharma and other cell and gene therapy biotech companies for workers. BMS Photo). BMS Photo). BMS’s Seattle labs.

Research 105

Research Engineering Programming Company 105

GeekWire

NOVEMBER 10, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies beat expectations for its fiscal third quarter as the Seattle company continues to use its immune medicine platform in the fight against COVID-19. based pharmaceutical giant that will use Adaptive’s clonoSEQ Assay for its hematology portfolio.

Biotechnology 65

Biotechnology Pharmaceuticals Development System 65

GeekWire

NOVEMBER 10, 2022

Epstein has more than 30 years of experience in the biopharmaceutical industry, including 25 years at Novartis, where he built the company’s oncology business unit up from its from inception, ultimately serving as CEO of Novartis Pharmaceuticals, a division of Novartis AG. He also will continue to serve as chief medical officer.

Development 83

Development Biotechnology Pharmaceuticals Oracle 83

GeekWire

JULY 29, 2021

And the Seattle region has had a major role in their development. Icosavax initiated a phase 1 and 2 clinical trial of a COVID-19 vaccine candidate this June, and is also developing shots against two viruses that cause pneumonia. Understanding what a robust immune response looks like could help inform the development of new vaccines.

Research 139

Research Study Biotechnology Development 139

Trends in the Living Networks

MARCH 23, 2011

Their joint work on a process for cloning genes in microorganisms resulted in three patents that formed the foundation of the nascent biotechnology industry. Do you need to come up with startlingly new and different ideas, or do you have to develop the seed of an idea into something useful and workable?

Open Source 138

Open Source Film Development Network 138

GeekWire

MAY 19, 2023

GeekWire Photo / Kevin Lisota) The gist: The Seattle startup is developing all electric powerboats for the retail market. Deal of the Year, presented by Wilson Sonsini Winner: Bungie Warren Rice, director of business development at Bungie, accepts the award for Deal of the Year at the 2023 GeekWire Awards. billion deal. billion deal.

Biotechnology 142

Biotechnology Microsoft Engineering Education 142

GeekWire

JANUARY 2, 2021

But even more important is to think about the technologies you are developing for the next long phase, which is about Resilience for the future. The tech industry has contributed to polarization through the various social media platforms that we developed. If 2020 was about Response, 2021 will be about Recovery.

Industry 145

Industry Sports Social CTO Hire 145

Trends in the Living Networks

AUGUST 11, 2022

She has worked on projects about diverse issues such as water security, the future of energy, the future of youth, intelligent buildings, the development of cities over the next few decades, and planning for Egypt in 2030. Chung developed the curriculum and conducted training for the government’s in-house futures course, Futurecraft.

Study 148

Study Research Trends Education 148

The Verge

AUGUST 31, 2021

But what really happened was in the late ‘80s into the 1990s, the US government invested huge amounts in genomics, the human genome program, biotechnology, molecular biology, life sciences, health sciences in general. Moderna, for example, had been working on it for a decade with $1 billion of private capital invested.

Intel 134

Intel Company Industry Tools 134